ResearcherIstanbul University-CerrahpaşaActive in the last 2 years

Fatemeh Bahadorı

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0003-4224-9309; OpenAlex author ID A5005735848.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: a novel approach using esculetin and curcumin. Last author DOI 10.1007/s00210-025-04455-7 ↗
Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment. Co-author DOI 10.1080/10837450.2020.1745232 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ayşe Karatuğ Kaçar · 1 shared paper, 2026
- Paper Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: a novel approach using esculetin and cur… DOI 10.1007/s00210-025-04455-7 ↗
Fahri Akbaş · 1 shared paper, 2020
- Paper Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic… DOI 10.1080/10837450.2020.1745232 ↗
şeyma Ceylan · 1 shared paper, 2020
- Paper Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic… DOI 10.1080/10837450.2020.1745232 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.